Natural vs IUI vs IVF: How to Decide Where to Start

You are at the start of treatment, or you are between treatments and trying to decide whether to step up. You are looking at three numbers (per-cycle success, total cost, and your age) and trying to figure out which path is your path. This post is the version of that conversation I have in clinic, with the per-cycle ranges, the landmark trials, and the decision frame laid out honestly rather than dressed up.

The short version. The choice between timed intercourse, IUI, and IVF is not a moral question or a stamina test. It is a question of which barrier you actually have, how old you are, and how much time and money each path costs to get you to a live birth. The success rate of IUI vs natural conception with timed intercourse is a real but moderate bump; the success rate of IUI vs IVF is a much larger gap, particularly above 38. The right path is the one whose cumulative live birth, given your barrier and your age, dominates the alternatives net of cost. The rest of this post is how to read that math.

The three paths in one paragraph each

Timed intercourse with or without oral medication: you track ovulation through basal body temperature, ovulation predictor kits, cervical mucus, or all three. You time intercourse to the fertile window. If you have anovulatory cycles or PCOS, you may add letrozole or clomid for five days each cycle. Per-cycle live birth in TTC populations is roughly 5 to 15 percent under 35, depending on diagnosis. This is the cheapest path and the slowest. It is the right tool when the only barrier is timing, anovulation that responds to oral medication, or short TTC duration in someone under 35.

IUI (intrauterine insemination): the partner's sperm is washed in the lab to concentrate motile sperm. The prepared sample is placed into the uterine cavity through a soft catheter on the day of ovulation, typically 24 to 36 hours after a trigger shot in a medicated cycle. Most US protocols pair IUI with letrozole or clomid. Per-cycle live birth is roughly 8 to 20 percent under 35, dropping with age. Mid-cost: $500 to $4,000 per cycle in the US. The right tool for mild male-factor infertility, unexplained infertility, cervical factor, donor sperm, and PCOS with anovulation despite oral medication and timed intercourse.

IVF (in vitro fertilization): daily injections of FSH for 8 to 14 days drive multiple follicles to maturity. Eggs are retrieved under sedation. Eggs and sperm are combined in the lab, with ICSI (intracytoplasmic sperm injection) for male-factor cases. Embryos develop for three to five days, and one is transferred to the uterus.

Per-cycle live birth in under-35s is 35 to 50 percent depending on diagnosis and counting (per egg retrieval, blastocyst transfer). Highest cost: $15,000 to $25,000+ per cycle in the US. The right tool for tubal disease, severe male-factor, age 38 and over, failed IUI ladder, time pressure, or when preimplantation genetic testing is needed.

Success rate of IUI vs natural: what per-cycle math tells you

The single most useful thing I can tell a couple at the start is that per-cycle live birth is not the number to plan around. Cumulative live birth across a defined treatment ladder is.

Per-cycle success is roughly independent through the first three to four attempts of any given treatment. That means probabilities multiply, not add. If your per-cycle live birth on letrozole-IUI is 12 percent, your cumulative live birth across three cycles is roughly 32 percent (1 minus 0.88 cubed). Across four cycles it is roughly 40 percent. The curve flattens after that.

A path is "right" when the cumulative live birth over your time horizon dominates the alternatives net of cost. That is the entire frame.

The landmark data here is the FORT-T trial (Goldman 2014, Fertility and Sterility). It randomised women aged 38 to 42 to a standard ladder of clomid-IUI, gonadotropin-IUI, then IVF versus an accelerated ladder of clomid-IUI then IVF (skipping gonadotropin-IUI).² The accelerated arm reached live birth significantly faster. For under-35s with unexplained infertility, IUI before IVF is still the standard ladder in most US guidelines and the ASRM 2020 unexplained infertility guideline supports it.⁵ The shape of the right ladder is age-dependent.

The decision framework I use with patients

I walk through four steps with couples at the first consult. It looks like this.

Step 1: identify the barrier: This is not "what is your diagnosis." It is "what is the specific reason a pregnancy has not happened?" Some barriers map to specific tools.

• Bilateral tubal disease or absent fallopian tubes: IVF (sperm and egg cannot meet in the tube; this is an absolute indication)
• Severe male-factor infertility (post-wash total motile count under 5 million on repeat samples): IVF with ICSI
• Anovulation: fix the ovulation first (oral medication with timed intercourse for a few cycles, then IUI if no pregnancy)
• Cervical factor or unexplained infertility: IUI fits well
• Stage III or IV endometriosis with anatomical distortion: IVF typically outperforms IUI substantially

Step 2: apply the age multiplier: Under 35, time is forgiving; mistakes can be corrected without a meaningful cost in egg quality. 35 to 37: be efficient with cycles. 38 to 40: every cycle costs eggs you cannot get back, and the FORT-T data argue against extended IUI ladders. 41 and over: IVF or the donor-egg conversation is the honest starting point, regardless of barrier.

Step 3: apply the cost and access reality: State mandates, employer benefits, IVF lifetime caps, insurance cycle-order requirements, and clinic packages all shape the math. A 33-year-old with unexplained infertility and full IVF coverage may go to IVF after one IUI. The same patient paying out of pocket may rationally do three IUIs first. The biology is the same; the math is different.

Step 4: apply your tolerance: IVF is more medication, more monitoring, more invasive, and harder on the body in a single cycle than IUI. Some couples need to feel they tried IUI before IVF; others need the highest-probability path now. Both are valid responses, and the right answer is the one you can sustain.

Comparison at a glance

A scannable table for the three paths. Numbers reflect typical US ranges across published series for someone with otherwise unremarkable diagnosis; your numbers vary by diagnosis, AMH, partner factors, and clinic.

	Timed intercourse	IUI	IVF
Per-cycle live birth, under 35	5 to 15 percent	8 to 20 percent	35 to 50 percent
Per-cycle live birth, 38 to 40	2 to 5 percent	5 to 10 percent	15 to 25 percent
Cost per cycle, US (rough)	$0 to $500	$500 to $4,000	$15,000 to $25,000+
Cycle length	1 month	1 month	6 to 8 weeks
Right for	Anovulation, short TTC, under 35	Mild MFI, unexplained, cervical, donor sperm	Tubal, severe MFI, 38+, failed IUI, PGT need

For the deeper by-age breakdown, see iui-success-rates-by-age and the comparable IVF view at ivf-success-rates-by-age. The SART national summary report in the US and HFEA in the UK are the best sources for benchmark per-cycle numbers by age band.⁷

Where each path is wrong

Naming the wrong-tool cases is sometimes more useful than naming the right-tool cases.

Timed intercourse is the wrong path when the barrier is mechanical (tubal disease, severe male-factor) or when age has compressed the time horizon. A 39-year-old with normal everything and a year of unsuccessful TTC has waited long enough; the right move is workup and treatment, not another six months of trying.

IUI is the wrong path when there is bilateral tubal disease or severe male-factor infertility. The biology will not let it work. Continuing to attempt IUI in these cases is not perseverance; it is using the wrong tool with full knowledge that it is the wrong tool.

IVF is the wrong path when there is no clear indication, you are under 35, and the cost is destabilising. Sometimes time, not technology, is the answer. The math under 35 with no severe factor often supports trying timed intercourse and a few IUI cycles first, particularly when IVF coverage is absent or partial.

What changes the math

Several variables flip the cleanest decision frame.

Strong donor sperm and no female-factor infertility: this is the cohort with the strongest IUI numbers in the literature, often 15 to 20 percent per cycle in under-35s. Natural-cycle donor-sperm IUI is rational, cost-efficient, and effective.

PCOS that ovulates on letrozole: three to four cycles of letrozole with timed intercourse first; IUI as the next step if no pregnancy after a few ovulatory cycles. The PALM/PPCOS-II trial supports letrozole over clomid for live birth in PCOS specifically.⁶

Mild male-factor with post-wash total motile count above 10 million: IUI is a reasonable starting protocol. Below 5 million, IVF with ICSI is the better tool; the thresholds are in iui-sperm-count-requirements.

Diminished ovarian reserve at any age: low AMH and high FSH compress the time horizon regardless of chronological age. Even a 32-year-old with AMH under 0.7 ng/mL is a candidate for an earlier-than-typical pivot to IVF.

Recurrent pregnancy loss: workup before any further treatment attempts, regardless of path. The loss pattern is the variable being investigated; adding another treatment cycle before the workup is finished is rarely the right move.

The "I want to try the cheap one first" trap

There is a real form of this that is reasonable. IUI is cheap enough to try when indicated, and a few well-monitored cycles can both produce pregnancies and serve as a diagnostic step that informs the next protocol.

There is also a sunk-cost form of this that traps couples. The trap looks like this. You are 39. You have done three medicated IUI cycles. None of them worked. Your insurance covers IVF.

You consider another IUI because three IUIs already cost you $7,500 and you "should at least give it one more shot." That is sunk-cost reasoning, and the next decision should not be made on the basis of money already spent. The next decision should be made on cumulative live birth from today forward, given the cycles remaining in your time horizon.

The counterpoint to this trap is the FORT-T data and the practical experience of moving people through the ladder. After three failed IUIs in someone 38 or over with confirmed ovulation each cycle, the per-cycle probability is not going to suddenly improve in cycle four. The reassessment is the conversation. third-iui-failed-what-now and when-to-skip-iui-go-ivf cover the transition.

When the decision is not actually yours

A few constraints can override the clinical calculus, and they are worth knowing.

Insurance: some US plans require three documented IUI cycles before they will cover IVF, regardless of clinical indication. This is administrative, not clinical. If your plan has this rule, the right strategy is sometimes to document failed IUIs efficiently rather than to optimise per-cycle probability on IUI. Your RE has seen this pattern; ask about it directly.

Clinic policies: some clinics will not perform IUI under certain male-factor cutoffs (typically post-wash total motile under 5 million) and will refer you out for ICSI. This is reasonable practice.

Logistics: donor sperm shipping timelines, gestational carrier matching, age cutoffs for donor egg programs, and the calendar of any planned surgery or oncology treatment all constrain the ladder.

Geography: in the UK, NHS-funded cycles vary by Integrated Care Board, and many funded cycles include strict eligibility criteria. NICE NG156 sets a national framework, but local commissioning practices differ.⁴

Common worries: what is normal, what is a red flag

A handful of questions land in the first or second consult that deserve direct answers.

"Am I being pushed to IVF too soon?" Ask for the reasoning. If the answer involves your age, your AMH, your antral follicle count, your partner's parameters, and the cumulative IUI math for your profile, the recommendation is probably appropriate. If the answer is "we usually do that here," push for the specifics.

"Am I giving up by skipping IUI?" No. The FORT-T trial supports skipping in older couples, and the ASRM 2020 unexplained-infertility guideline integrates that data.⁵ Skipping a low-probability tool to use a higher-probability one is not surrender; it is treatment matched to barrier.

"Will I regret not trying IUI first?" Sometimes yes. The regret is real and worth naming, even when the math says otherwise. This is part of why we have the conversation up front. A couple that needs to feel they tried IUI to be at peace with IVF later is a couple I will often support with one or two letrozole-IUI cycles, even when the math leans toward IVF. That is true particularly when age allows it.

How to leave your decision consult with clarity

A useful checklist for the end of a treatment-decision appointment.

1. A named indication for the chosen path. Not "unexplained" alone; "unexplained infertility, age 33, two years of attempts, normal HSG, AMH 2.4, partner post-wash TMC 30 million, recommend letrozole-IUI for three cycles" is the right level of specificity.
2. A named number of cycles before reassessment.
3. A defined off-ramp: what triggers IVF, what triggers stopping, what would change the recommendation mid-ladder.
4. A cost estimate from the clinic's financial counsellor, not the website. Pricing varies by specifics, and the financial counsellor is the right person to walk you through your insurance benefit.
5. A timeline you and your partner have agreed to before walking out of the consult.

What you can do this week

Two practical pieces if you are at the start of this decision.

Bring your most recent labs and your partner's most recent semen analysis to the decision consult in writing. AMH, antral follicle count, day-3 FSH, day-3 estradiol, prolactin, TSH, HSG result (if done), and a semen analysis from within the last 12 months. Decisions made without these are decisions made on assumption.

Have the cost conversation with the clinic's financial counsellor before you commit to a protocol. Per-cycle costs vary widely between clinics for the same nominal protocol, and refund programmes and package pricing for IVF can change the math meaningfully. The success rate of IUI vs natural conception is real but moderate; the success rate of IUI vs IVF widens fast with age. The right path is the one whose cumulative live birth wins the math you are actually running.

What's next

• For the by-age IUI numbers: iui-success-rates-by-age
• For the IVF side of the comparison: ivf-success-rates-by-age
• For the cost-benefit math of multiple IUIs vs one IVF: iui-cost-benefit-vs-ivf
• For the explicit transition decision: when-to-skip-iui-go-ivf
• For the timed-intercourse-with-letrozole path: letrozole-vs-clomid
• If three IUIs have not worked: third-iui-failed-what-now

Sources

1. Reindollar RH, Regan MM, Neumann PJ, et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the Fast Track and Standard Treatment (FASTT) trial. Fertility and Sterility 2010;94(3):888-899. Link
2. Goldman MB, Thornton KL, Ryley D, et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertility and Sterility 2014;101(6):1574-1581.e2. Link
3. Diamond MP, Legro RS, Coutifaris C, et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility. New England Journal of Medicine 2015;373(13):1230-1240. Link
4. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE guideline NG156. 2013, updated 2017. Link
5. Practice Committee of the American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertility and Sterility 2020;113(2):305-322. Link
6. ESHRE Guideline Group on Unexplained Infertility. ESHRE guideline: unexplained infertility. Human Reproduction Open 2023;2023(1):hoad007. Link
7. Society for Assisted Reproductive Technology. National Summary Report. SART CORS. Link